Jin QQ - Search Results

1

[Clinical Features and Prognostic of Patients with Primary Central Nervous System Lymphoma].

Zhang LT, Li CC, Jin QQ, Jiang HY, Yue NN, Zeng PY, Yue LL, Wu CY. Zhang LT, et al. Among authors: jin qq. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Jun;32(3):723-732. doi: 10.19746/j.cnki.issn.1009-2137.2024.03.011. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024. PMID: 38926959 Chinese.

2

Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma.

Jin Q, Jiang H, Han Y, Li C, Zhang L, Zhang Y, Chai Y, Zeng P, Yue L, Wu C. Jin Q, et al. World Neurosurg. 2023 Feb;170:99-106. doi: 10.1016/j.wneu.2022.11.056. Epub 2022 Nov 15. World Neurosurg. 2023. PMID: 36396049 Review.

3

[Prognostic Value of A New Risk Stratification Model (R2-ISS) in Newly Diagnosed Multiple Myeloma].

Wang Y, Yue LL, Zeng PY, Wu CY, Han Y, Song Y, Jin QQ, Jiang HY, Chai Y. Wang Y, et al. Among authors: jin qq. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Dec;30(6):1779-1784. doi: 10.19746/j.cnki.issn.1009-2137.2022.06.023. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 36476903 Chinese.

4

CD39 (ENTPD1) in tumors: a potential therapeutic target and prognostic biomarker.

Li C, Zhang L, Jin Q, Jiang H, Wu C. Li C, et al. Biomark Med. 2023 Jun;17(12):563-576. doi: 10.2217/bmm-2023-0202. Epub 2023 Sep 15. Biomark Med. 2023. PMID: 37713234 Review.

5

[The Prognostic Value of Prognostic Nutritional Index Combined with D-dimer in Patients with Diffuse Large B-Cell Lymphoma].

Han Y, Song Y, Wang Y, Jin QQ, Jiang HY, Chai Y, Zeng PY, Yue LL, Wu CY. Han Y, et al. Among authors: jin qq. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Oct;31(5):1385-1393. doi: 10.19746/j.cnki.issn.1009-2137.2023.05.021. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 37846689 Chinese.

6

Role and application of chemokine CXCL13 in central nervous system lymphoma.

Li C, Zhang L, Jin Q, Jiang H, Wu C. Li C, et al. Ann Hematol. 2024 Aug;103(8):2671-2680. doi: 10.1007/s00277-023-05560-4. Epub 2023 Nov 27. Ann Hematol. 2024. PMID: 38010409 Review.

7

The prognostic value of CD8⁺ CTLs, CD163⁺ TAMs, and PDL1 expression in the tumor microenvironment of primary central nervous system lymphoma.

Jin Q, Jiang H, Yue N, Zhang L, Li C, Dong C, Zeng P, Yue L, Wu C. Jin Q, et al. Leuk Lymphoma. 2024 Apr;65(4):472-480. doi: 10.1080/10428194.2023.2296364. Epub 2024 Jan 10. Leuk Lymphoma. 2024. PMID: 38198635

8

[Whole Exome Sequencing Reveals Gene Mutation Characteristics of Primary Central Nervous System Lymphoma].

Jin QQ, Jiang HY, Han Y, Li CC, Zhang LT, Wu CY. Jin QQ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Jun;32(3):756-762. doi: 10.19746/j.cnki.issn.1009-2137.2024.03.015. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024. PMID: 38926963 Chinese.

9

CD36: a promising therapeutic target in hematologic tumors.

Yue N, Jin Q, Li C, Zhang L, Cao J, Wu C. Yue N, et al. Leuk Lymphoma. 2024 Dec;65(12):1749-1765. doi: 10.1080/10428194.2024.2376178. Epub 2024 Jul 9. Leuk Lymphoma. 2024. PMID: 38982639 Review.

10

Recent advances in CD5⁺ diffuse large B-cell lymphoma.

Yue N, Jin Q, Li C, Zhang L, Cao J, Wu C. Yue N, et al. Ann Hematol. 2024 Nov;103(11):4401-4412. doi: 10.1007/s00277-024-05974-8. Epub 2024 Aug 28. Ann Hematol. 2024. PMID: 39196380 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters